UK Healthcare Group Limited - Period Ending 2023-07-31
UK Healthcare Group Limited - Period Ending 2023-07-31
Registration number:
UK Healthcare Group Limited
for the Year Ended 31 July 2023
Pages for filing with Registrar
UK Healthcare Group Limited
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
UK Healthcare Group Limited
Company Information
Directors |
R P Jupp M E Wills |
Registered office |
|
Registered number |
05314436 |
Accountants |
|
UK Healthcare Group Limited
(Registration number: 05314436)
Balance Sheet as at 31 July 2023
Note |
2023 |
2022 |
|
Fixed assets |
|||
Tangible assets |
|
- |
|
Investment property |
|
|
|
Investments |
|
|
|
|
|
||
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
Total equity |
|
|
UK Healthcare Group Limited
(Registration number: 05314436)
Balance Sheet as at 31 July 2023
For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised for issue by the
.........................................
Director
UK Healthcare Group Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023
Statutory information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
United Kingdom
Accounting policies |
Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention.
The financial statements are prepared in pounds sterling which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Going concern
The company's financial statements have been prepared on a going concern basis. The directors have considered a period of twelve months from the date of approval of the financial statements and believe that the company is able to meet liabilities as they fall due.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
UK Healthcare Group Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Tangible fixed assets
Tangible fixed assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible fixed assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Motor vehicles |
25% reducing balance |
Investment property
Business combinations
Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.
Investments
Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.
UK Healthcare Group Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Tangible fixed assets |
Motor vehicles |
|
Cost |
|
Additions |
|
At 31 July 2023 |
|
Depreciation |
|
Charge for the year |
|
At 31 July 2023 |
|
Carrying amount |
|
At 31 July 2023 |
|
At 31 July 2022 |
- |
Investment properties |
2023 |
|
At 1 August 2021 |
|
At 31 July 2022 |
|
Investment property is carried at fair value, determined by the directors with reference to the condition and location of the property, as well as current, observable market prices. There has been no valuation of investment property by an independent valuer.
UK Healthcare Group Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023
Investments |
2023 |
2022 |
|
Investments in subsidiaries |
|
|
FRS 102 does not require disclosure of transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly-owned by such a member.
Debtors: amounts falling due within one year |
2023 |
2022 |
|
Amounts owed by group undertakings |
|
|
|
|
Creditors |
2023 |
2022 |
|
Amounts falling due within one year |
||
Amounts owed to group undertakings |
- |
|
Taxation and social security |
|
- |
Other creditors |
|
- |
Accruals |
2,100 |
1,500 |
|
|
Share capital |
Allotted, called up and fully paid shares
2023 |
2022 |
|||
No. |
£ |
No. |
£ |
|
|
|
1.00 |
|
1.00 |
UK Healthcare Group Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023
Related party transactions |
Loans to related parties
2023 |
Entities with joint control or significant influence |
|
|
|
2022 |
Entities with joint control or significant influence |
- |
|
|
Parent undertaking and ultimate controlling party |
The company's immediate parent company and ultimate controlling party is Southern & Western Support Ltd, incorporated in England and Wales.